Literature DB >> 6112261

Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone.

A J Osbahr, C B Nemeroff, D Luttinger, G A Mason, A J Prange.   

Abstract

Neurotensin (NT), administered intracisternally to mice, produced significant dose-dependent antinociception in three analgesic tests: tail immersion, hot-plate and acetic acid writhing. Naloxone (1-5 mg/kg), an opiate antagonist administered i.p. 20 min before NT administration, did not significantly alter NT-induced antinociception in any of these tests; naloxone did significantly reverse beta-endorphin-induced antinociception. However, centrally and peripherally administered thyrotropin-releasing hormone antagonized NT-induced (but not beta-endorphin-induced) antinociception. Equimolar doses of another tripeptide (Pro-Leu-Gly-NH2; melanostatin) did not alter the effects of NT. The data obtained in this study confirm NT-induced antinociception, provide further evidence that NT does not activate naloxone-sensitive opiate receptors and demonstrate that this brain effect of NT is antagonized by thyrotropin-releasing hormone. These findings therefore support the hypothesis that NT and thyrotropin-releasing hormone are functional antagonists in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112261

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

Review 2.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

3.  Structure-antinociceptive activity studies with neurotensin.

Authors:  S Furuta; K Kisara; S Sakurada; T Sakurada; Y Sasaki; K Suzuki
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

4.  The effects of chronic morphine treatment on neurotensin-induced antinociception.

Authors:  D Luttinger; S K Burgess; C B Nemeroff; A J Prange
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Distribution of NT-IR perikarya in the brain of the guinea pig with special reference to cardiovascular centers in the medulla oblongata.

Authors:  J Triepel; J Mader; A Weindl; D Heinrich; W G Forssmann; J Metz
Journal:  Histochemistry       Date:  1984

6.  Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Authors:  Michel Demeule; Nicolas Beaudet; Anthony Régina; Élie Besserer-Offroy; Alexandre Murza; Pascal Tétreault; Karine Belleville; Christian Ché; Alain Larocque; Carine Thiot; Richard Béliveau; Jean-Michel Longpré; Éric Marsault; Richard Leduc; Jean E Lachowicz; Steven L Gonias; Jean-Paul Castaigne; Philippe Sarret
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

7.  Antinociceptive properties of thyrotropin releasing hormone in mice: comparison with morphine.

Authors:  G Boschi; M Desiles; V Reny; R Rips; S Wrigglesworth
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

8.  The effects of neurotensin, beta-endorphin, and bombesin on ethanol-induced behaviors in mice.

Authors:  D Luttinger; G D Frye; C B Nemeroff; A J Prange
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 9.  To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.

Authors:  Juliette A Brown; Hillary L Woodworth; Gina M Leinninger
Journal:  Front Syst Neurosci       Date:  2015-02-18

10.  Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.

Authors:  Geneviève Roussy; Marc-André Dansereau; Stéphanie Baudisson; Faouzi Ezzoubaa; Karine Belleville; Nicolas Beaudet; Jean Martinez; Elliott Richelson; Philippe Sarret
Journal:  Mol Pain       Date:  2009-07-06       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.